ER 4 2.25 (Pramipexole Dihydrochloride Extended-Release 2.25 mg)
Pill with imprint ER 4 2.25 is White, Elliptical / Oval and has been identified as Pramipexole Dihydrochloride Extended-Release 2.25 mg. It is supplied by Macleods Pharmaceuticals Limited.
Pramipexole is used in the treatment of restless legs syndrome; parkinson's disease; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 2.25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ER 4 2.25
Pramipexole Dihydrochloride Extended-Release
- Imprint:
- ER 4 2.25
- Strength:
- 2.25 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Macleods Pharmaceuticals Limited
- National Drug Code (NDC):
- 33342-0211
More about pramipexole
- Pramipexole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 155 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
Other brands: Mirapex, Mirapex ER
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
